{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:24:38Z","timestamp":1773325478769,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold> After hepatitis B virus (HBV) e antigen (HBeAg) seroconversion, HBV\u2010DNA continues to replicate, and HBeAg\u2010negative patients still face the risk of liver disease progression. We investigated the predictive factors for alanine aminotransferase (ALT) elevation, antiviral drug use, and hepatocellular carcinoma (HCC) occurrence in HBeAg\u2010negative patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Age, sex, ALT, platelet counts, HBV\u2010DNA levels, genotype, antidiabetic drug use, body mass index, smoking, and alcohol consumption were analyzed for a total of 244 HBV carriers who were HBeAg\u2010negative.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Of 244 HBeAg\u2010negative patients, 158 (64.8%) showed normal ALT levels at baseline. Multivariate Cox hazard regression analysis identified high HBV\u2010DNA levels and high ALT at baseline as independent risk factors for ALT elevation in the patients with normal ALT at baseline. The threshold ALT and HBV\u2010DNA levels were determined to be 31\u2003IU\/L and 5.3 logcopies\/mL, respectively. Seventeen (7.0%) patients used antiviral drugs. Multivariate Cox hazard regression analysis identified high HBV\u2010DNA levels (threshold, 5.7 log copies\/mL), the use of antidiabetic drugs, and daily alcohol consumption at baseline as an independent risk factor for the use of antiviral drugs in HBeAg\u2010negative patients. In 10 patients (4.1%), HCC was detected, and a low platelet count (threshold, 10.0\u2003\u00d7\u200310<jats:sup>4<\/jats:sup>\/mm<jats:sup>3<\/jats:sup>) was associated with the occurrence of HCC.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> This study identified predictors of future active liver disease in HBeAg\u2010negative patients, i.e. ALT elevation, unavoidable use of antiviral drugs, and occurrence of HCC.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2010.06322.x","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T10:19:46Z","timestamp":1269253186000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long\u2010term follow\u2010up of patients with hepatitis B e antigen negative chronic hepatitis B"],"prefix":"10.1111","volume":"26","author":[{"given":"Dan","family":"Bekku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Imazeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yonemitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Itoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yokosuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.011"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300109"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.128496"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-6-744"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-8-629"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50036"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21585"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21811"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27221"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00453.x-i1"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i43.6848"},{"key":"e_1_2_5_13_2","first-page":"143","article-title":"Long\u2010term morbidity and mortality in Chinese insurance applicants infected with the hepatitis B virus","volume":"33","author":"Pokorski RJ","year":"2001","journal-title":"J. Insur. Med."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018870709286"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.075"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1994.tb00071.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21627"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01733.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.07.022"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.11.016"},{"key":"e_1_2_5_21_2","first-page":"183","article-title":"Dynamics of HBV DNA levels, HBV mutations and biochemical parameters during antiviral therapy in a patient with HBeAg\u2010negative chronic hepatitis B","volume":"25","author":"Sa\u2010nguanmoo P","year":"2007","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"e_1_2_5_22_2","first-page":"292","article-title":"Treatment of chronic hepatitis B virus infection\u2014Dutch national guidelines","volume":"66","author":"Buster EH","year":"2008","journal-title":"Neth. J. Med."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.075"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.056"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.044"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2010.06322.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2010.06322.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:45:55Z","timestamp":1697337955000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2010.06322.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1440-1746.2010.06322.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06322.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]},"assertion":[{"value":"2010-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}